Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. C R V Tomson, past chair, Joint Specialty Committee on Renal Medicine of the Renal Association and the Royal College of Physicians1,
  2. E J Lamb, consultant clinical scientist2,
  3. K Griffith, general practitioner3,
  4. D O'Donoghue, national clinical director of kidney care4,
  5. J Feehally, immediate past president, Renal Association5
  1. 1Renal Medicine, Southmead Hospital, Bristol BS10 5NB
  2. 2Clinical Biochemistry, East Kent Hospitals NHS Trust, Kent and Canterbury Hospital, Canterbury CT1 3NG
  3. 3University Health Centre, York University, York YO10 5DD
  4. 4Department of Nephrology, Salford Royal Hospital NHS Trust, Hope Hospital, Salford M6 8HD
  5. 5John Walls Renal Unit, Leicester General Hospital, Leicester LE5 4 PW
  1. edmund.lamb{at}ekht.nhs.uk

    Giles and Fitzmaurice's arguments are designed to persuade BMJ readers that reporting estimated glomerular filtration rate (eGFR) has introduced a screening programme by the back door, will pressurise specialist services, and cause unnecessary anxiety and harm to patients in terms of getting life insurance and receiving inappropriate treatment.1

    The marked increase in referrals of patients with …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular